Daiichi Sankyo

Daiichi Sankyo is a global pharmaceutical company headquartered in Tokyo, Japan, specializing in the research, development, and marketing of innovative medicines. They generate revenue primarily through the sale of prescription drugs, with a strong focus on oncology, cardiovascular, and metabolic therapies. Founded in 2005 through the merger of Daiichi Pharmaceutical and Sankyo Co., Ltd., the company has a rich history of scientific innovation and strategic partnerships, including a notable acquisition of Ranbaxy Laboratories in 2008.

Recent Posts by Daiichi Sankyo

1-20 of 115